Procalcitonin Test for Differentiation of the Cause of Pneumonia

National Cancer Center (NCC)

Status: Completed

Conditions: Procalcitonin; Cancer; Pneumonia

Treatments: Diagnostic Test: procalcitonin test

Study type: Observational

Funder types: Other

Identifiers

NCT03350802

NCC2014-0018

Details and patient eligibility

About

The purpose of this study is to evaluate the usefulness of procalcitonin test for differentiation of the cause of pneumonia in patients with cancer.

Full description

Serum procalcitonin test is currently used as the biomarker for bacterial infection. Especially, procalcitonin test has been reported to be helpful in differentiating bacterial pneumonia from viral pneumonia, acute exacerbations of interstitial pneumonitis or chronic obstructive lung disease. However, it is not known whether procalcitonin test can help distinguish bacterial pneumonia from non-bacterial pneumonia such as radiation pneumonitis or chemotherapy-induced pneumonitis in patients with cancer.

The aim of this prospective cohort study is to observe the clinical benefits of procalcitonin test for differentiation of the cause of pneumonia in patients with cancer.

Enrollment: 649 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Age greater than 18 years
• Patients who have symptoms and suspected imaging findings compatible with pneumonia

Exclusion criteria

• Patients who have been treated with antibiotics or steroid therapy.

Trial design

649 participants in 1 patient group

procalcitonin pneumonia cohort

Description:

Patients who are suspected of acute pneumonia due to symptoms and imaging findings compatible with pneumonia can be enrolled in this cohort.

Treatment:

Diagnostic Test: procalcitonin test